Suppr超能文献

儿童肠衰竭的运动障碍:国家三级转诊中心的经验。

Motility disorders in children with intestinal failure: a national tertiary referral center experience.

机构信息

Department of Pediatric Surgery, Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

出版信息

Pediatr Surg Int. 2022 Dec;38(12):1737-1743. doi: 10.1007/s00383-022-05223-x. Epub 2022 Sep 17.

Abstract

PURPOSE

Intestinal dysmotility (ID) problems are common in patients with pediatric-onset intestinal failure (IF) and short bowel syndrome (SBS), leading to significant morbidity and delays in the advancement of enteral nutrition (EN). We aimed to investigate the clinical features and complications of ID in children with IF and SBS.

METHODS

Retrospective chart review of all children with IF and/or SBS who required parenteral nutrition (PN) > 6 weeks or small-intestinal resection ≥ 50%. Patients were divided into SBS and non-SBS groups. SBS group was divided into two subgroups: with and without ID. Patients with ID were identified (clinically, radiologically and functionally) and analyzed with regard to demographics, intestinal anatomy, complications and outcomes (short and long term).

RESULTS

A total of 42 children with IF were treated in our institution during 2003-2022. In non-SBS group (n = 10), ID was the most common cause of IF (80%). SBS-group included 32 children; 18 children (56%) developed ID. The clinical profile of SBS-ID patients (vs SBS) was: female gender (56%), remaining small bowel length ≤ 55 cm, estimated residual small bowel ≤ 28% (p = 0.045) and absence of ICV (56%). Common symptoms of the SBS-ID group were: food intolerance (61%), abdominal distension (50%), vomiting (44%), malabsorption and severe constipation. Complications included FTT (67%) (p = 0.003), bacterial overgrowth with subsequent bloodstream infection (33%) (p = 0.75), and lactic acidosis (11%). Lengthening procedure (STEP) was performed in 11 SBS-ID patients (61%) (p = 0.002). In all patients, STEP operation "rescued" their dysfunctional intestine. Eight of these patients (73%) were weaned from TPN. Survival rate was 100%; however, one SBS-ID patient is a candidate for combined intestinal and liver transplantation.

CONCLUSIONS

ID is the most common complication of SBS and is the most common cause of IF in non-SBS patients. ID has a high morbidity rate and various clinical manifestations. Successful treatment of these infants may be achieved with the use of tapering enteroplasty.

摘要

目的

肠动力障碍(ID)问题在儿科起病的肠衰竭(IF)和短肠综合征(SBS)患者中很常见,导致发病率显著增加,并延迟了肠内营养(EN)的推进。我们旨在研究 ID 患儿 IF 和 SBS 的临床特征和并发症。

方法

回顾性分析所有需要肠外营养(PN)>6 周或小肠切除≥50%的 IF 和/或 SBS 患儿的图表。将患者分为 SBS 和非 SBS 组。SBS 组再分为有 ID 和无 ID 两组。通过临床、放射和功能方面识别 ID 患者,并分析其人口统计学、肠道解剖、并发症和结果(短期和长期)。

结果

2003-2022 年,我院共收治 42 例 IF 患儿。非 SBS 组(n=10)中,ID 是 IF 的最常见原因(80%)。SBS 组包括 32 例患儿,其中 18 例(56%)发生 ID。SBS-ID 患者(与 SBS 相比)的临床特征为:女性(56%),残留小肠长度≤55cm,估计残留小肠长度≤28%(p=0.045)和无 ICV(56%)。SBS-ID 组的常见症状为:食物不耐受(61%)、腹胀(50%)、呕吐(44%)、吸收不良和严重便秘。并发症包括 FTT(67%)(p=0.003)、细菌过度生长伴随后续血流感染(33%)(p=0.75)和乳酸性酸中毒(11%)。11 例 SBS-ID 患者(61%)进行了 STEP 手术(p=0.002)。所有患者的 STEP 手术均“挽救”了其功能失调的肠道。其中 8 例(73%)患者成功脱离 TPN。生存率为 100%;然而,1 例 SBS-ID 患者是联合肠和肝移植的候选者。

结论

ID 是 SBS 最常见的并发症,也是非 SBS 患者 IF 最常见的原因。ID 发病率高,临床表现多样。使用逐渐变细的肠成形术可以成功治疗这些婴儿。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验